A Al-Hendy, R Venturella, JCA Ferreira, Y Li… - American Journal of …, 2023 - ajog.org
Background In the pivotal LIBERTY 1 and 2 trials and long-term extension study, once-daily
relugolix combination therapy (40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone …